Ameritas Advisory Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.2K | Buy |
+1,128
| New | +$88.2K | ﹤0.01% | 1042 |
|
|
2024
Q2 | – | Sell |
-3,269
| Closed | -$311K | – | 904 |
|
|
2024
Q1 | $311K | Buy |
+3,269
| New | +$311K | 0.01% | 699 |
|
|
2023
Q2 | – | Sell |
-2,765
| Closed | -$237K | – | 1155 |
|
|
2023
Q1 | $237K | Sell |
2,765
-1,998
| -42% | -$171K | 0.01% | 716 |
|
|
2022
Q4 | $355K | Buy |
4,763
+1,948
| +69% | +$145K | 0.02% | 652 |
|
|
2022
Q3 | $233K | Buy |
2,815
+39
| +1% | +$3.23K | 0.01% | 669 |
|
|
2022
Q2 | $264K | Sell |
2,776
-30
| -1% | -$2.85K | 0.02% | 659 |
|
|
2022
Q1 | $330K | Sell |
2,806
-247
| -8% | -$29K | 0.01% | 632 |
|
|
2021
Q4 | $395K | Buy |
+3,053
| New | +$395K | 0.01% | 566 |
|